{"disease":{"id":"oligometastatic-disease","name":"oligometastatic disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06356779","title":"Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Gitte Fredberg Persson MD PhD","has_results":false},{"nct_id":"NCT05352178","title":"Metastasis-directed Therapy for Oligorecurrent Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":873,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT05784428","title":"Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression","phase":"NA","overall_status":"RECRUITING","enrollment_count":598,"lead_sponsor_name":"Robert Olson","has_results":false},{"nct_id":"NCT06430411","title":"Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04593381","title":"Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Gemelli Molise Hospital","has_results":false},{"nct_id":"NCT06190782","title":"Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":354,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05377047","title":"Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":345,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT05679427","title":"Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions","phase":"NA","overall_status":"RECRUITING","enrollment_count":307,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06462963","title":"OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":302,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT06918951","title":"Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT05278052","title":"Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT01345552","title":"Radiosurgery for Patients Recurrent Oligometastatic Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Steven Burton","has_results":false},{"nct_id":"NCT04617457","title":"Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT05951127","title":"Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":141,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05223803","title":"TERPS Trial for de Novo Oligometastic Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05277844","title":"Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT06652022","title":"Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs","phase":"NA","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT06556550","title":"Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Medical Research Radiological Centre of the Ministry of Health of Russia","has_results":false},{"nct_id":"NCT05375708","title":"Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":93,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT06212583","title":"High-Risk Metachronous Oligometastatic Prostate Cancer Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05862051","title":"RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Australasian Gastro-Intestinal Trials Group","has_results":false},{"nct_id":"NCT06668454","title":"Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05101824","title":"Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":67,"lead_sponsor_name":"Gitte Fredberg Persson MD PhD","has_results":false},{"nct_id":"NCT04141709","title":"Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT05128201","title":"Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT05648370","title":"Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT06299852","title":"Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":58,"lead_sponsor_name":"N.N. Petrov National Medical Research Center of Oncology","has_results":false},{"nct_id":"NCT06121700","title":"Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05183074","title":"MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05626569","title":"Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04821765","title":"Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT01345539","title":"Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Steven Burton","has_results":true},{"nct_id":"NCT06842030","title":"Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Good Samaritan Hospital Medical Center, New York","has_results":false},{"nct_id":"NCT04973007","title":"Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05846646","title":"Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"ImmuneSensor Therapeutics Inc.","has_results":true},{"nct_id":"NCT06122480","title":"Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma","phase":"NA","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}